Equity Details
Price & Market Data
Price: $2.09
Daily Change: +$0.06 / 2.87%
Daily Range: $1.97 - $2.12
Market Cap: $201,336,560
Daily Volume: 1,762,425
Performance Metrics
1 Week: 5.18%
1 Month: 4.10%
3 Months: 29.30%
6 Months: -2.87%
1 Year: 148.1%
YTD: 27.67%
About Caribou Biosciences, Inc. (CRBU)
Dive into the latest financial snapshot of Caribou Biosciences, Inc. (CRBU). With a current trading price of 2.09, the stock has experienced a daily shift of +$0.06 / 2.87%. The company's market capitalization stands impressively at 201,336,560. Track its year-to-date performance, which is at 27.67%, alongside its weekly, monthly, and yearly trends.
Company Details
Employees: 97
Sector: Health technology
Industry: Biotechnology
Country: United States
Details
Caribou Biosciences, Inc. operates as a clinical-stage clustered regularly interspaced short palindromic repeats (CRISPR) genome-editing biopharmaceutical company. It offers a genome-editing platform based on novel CRISPR hybrid RNA-DNA genome-editing technology that enables precise genome editing of allogeneic cell therapies. The company develops Vispacabtagene Regedleucel, an allogeneic anti-CD19 CAR-T cell therapy that is in phase 1 clinical trial to treat relapsed or refractory B cell non-Hodgkin lymphoma; and CB-011, an allogeneic anti-BCMA CAR-T cell therapy that is in phase 1 clinical trial for the treatment of relapsed or refractory multiple myeloma. Caribou Biosciences, Inc. was incorporated in 2011 and is headquartered in Berkeley, California.